Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 152 | 2024 | 13262 | 7.380 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 82 | 2024 | 5251 | 5.940 |
Why?
|
Thymus Neoplasms | 8 | 2023 | 274 | 3.130 |
Why?
|
Adenocarcinoma | 41 | 2023 | 6315 | 2.880 |
Why?
|
Immunohistochemistry | 56 | 2022 | 11071 | 2.590 |
Why?
|
High-Throughput Nucleotide Sequencing | 46 | 2024 | 3616 | 2.470 |
Why?
|
Mutation | 95 | 2024 | 29932 | 2.430 |
Why?
|
Gene Amplification | 7 | 2023 | 1085 | 1.920 |
Why?
|
Gene Rearrangement | 13 | 2024 | 1122 | 1.900 |
Why?
|
Pleural Neoplasms | 5 | 2023 | 609 | 1.890 |
Why?
|
Testicular Neoplasms | 14 | 2023 | 801 | 1.860 |
Why?
|
DNA Mutational Analysis | 25 | 2024 | 4107 | 1.640 |
Why?
|
Proto-Oncogene Proteins c-met | 12 | 2024 | 567 | 1.620 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 26 | 2023 | 1728 | 1.560 |
Why?
|
In Situ Hybridization, Fluorescence | 27 | 2023 | 2506 | 1.540 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2022 | 421 | 1.460 |
Why?
|
Thymoma | 3 | 2023 | 187 | 1.420 |
Why?
|
DNA, Neoplasm | 6 | 2020 | 1745 | 1.410 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 7 | 2023 | 113 | 1.320 |
Why?
|
DNA Mismatch Repair | 7 | 2023 | 429 | 1.320 |
Why?
|
Mesothelioma | 4 | 2023 | 807 | 1.270 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2023 | 487 | 1.250 |
Why?
|
Pathology, Molecular | 6 | 2023 | 329 | 1.120 |
Why?
|
Neoplastic Syndromes, Hereditary | 6 | 2024 | 243 | 1.120 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2023 | 346 | 1.050 |
Why?
|
Neoplasms | 26 | 2024 | 22072 | 1.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 8 | 2021 | 1613 | 1.020 |
Why?
|
Humans | 306 | 2024 | 760621 | 0.930 |
Why?
|
Genomics | 25 | 2024 | 5794 | 0.910 |
Why?
|
Endometrial Neoplasms | 6 | 2023 | 1357 | 0.880 |
Why?
|
Oncogene Proteins | 4 | 2018 | 719 | 0.870 |
Why?
|
Carcinoma, Large Cell | 2 | 2014 | 113 | 0.860 |
Why?
|
Transcription Factors | 16 | 2023 | 12103 | 0.840 |
Why?
|
Protein Kinase Inhibitors | 28 | 2024 | 5643 | 0.820 |
Why?
|
Purine-Nucleoside Phosphorylase | 2 | 2022 | 28 | 0.810 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2021 | 4024 | 0.810 |
Why?
|
Proto-Oncogene Proteins | 13 | 2024 | 4490 | 0.800 |
Why?
|
Colorectal Neoplasms | 13 | 2024 | 6853 | 0.790 |
Why?
|
Receptor, trkC | 1 | 2021 | 63 | 0.790 |
Why?
|
Receptor, erbB-2 | 4 | 2023 | 2554 | 0.780 |
Why?
|
Gene Fusion | 3 | 2021 | 354 | 0.780 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2023 | 1596 | 0.760 |
Why?
|
Nuclear Proteins | 15 | 2023 | 5791 | 0.750 |
Why?
|
Protein-Tyrosine Kinases | 9 | 2024 | 2418 | 0.740 |
Why?
|
Mediastinal Diseases | 1 | 2021 | 91 | 0.730 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2021 | 698 | 0.730 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2021 | 198 | 0.730 |
Why?
|
Thymus Hyperplasia | 3 | 2015 | 32 | 0.720 |
Why?
|
Cytogenetics | 2 | 2021 | 198 | 0.710 |
Why?
|
Incidental Findings | 3 | 2024 | 698 | 0.710 |
Why?
|
Maxillary Sinus Neoplasms | 2 | 2018 | 39 | 0.710 |
Why?
|
Aged | 114 | 2024 | 169152 | 0.700 |
Why?
|
Carcinoma | 6 | 2019 | 2331 | 0.700 |
Why?
|
Camptothecin | 1 | 2023 | 590 | 0.700 |
Why?
|
Maxillary Neoplasms | 1 | 2020 | 47 | 0.700 |
Why?
|
Odontogenic Cysts | 1 | 2020 | 42 | 0.700 |
Why?
|
Splenomegaly | 1 | 2020 | 189 | 0.690 |
Why?
|
Odontogenic Tumors | 1 | 2020 | 45 | 0.680 |
Why?
|
Heart Neoplasms | 1 | 2023 | 360 | 0.680 |
Why?
|
Genetic Markers | 3 | 2017 | 2608 | 0.680 |
Why?
|
Choristoma | 1 | 2021 | 207 | 0.670 |
Why?
|
Middle Aged | 125 | 2024 | 220352 | 0.670 |
Why?
|
Sarcoma | 5 | 2022 | 1786 | 0.660 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.650 |
Why?
|
Peritoneal Neoplasms | 3 | 2020 | 707 | 0.650 |
Why?
|
Mandibular Neoplasms | 1 | 2020 | 130 | 0.650 |
Why?
|
SOXB1 Transcription Factors | 2 | 2010 | 286 | 0.620 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 370 | 0.620 |
Why?
|
Pseudolymphoma | 2 | 2015 | 30 | 0.610 |
Why?
|
Female | 146 | 2024 | 391270 | 0.600 |
Why?
|
Soft Tissue Neoplasms | 6 | 2022 | 1152 | 0.600 |
Why?
|
Myeloproliferative Disorders | 2 | 2017 | 609 | 0.590 |
Why?
|
Drug Resistance, Neoplasm | 15 | 2024 | 5253 | 0.590 |
Why?
|
Male | 139 | 2024 | 359744 | 0.590 |
Why?
|
Aged, 80 and over | 52 | 2024 | 58995 | 0.580 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2023 | 494 | 0.580 |
Why?
|
Pneumonectomy | 1 | 2024 | 1111 | 0.580 |
Why?
|
Translocation, Genetic | 5 | 2017 | 1388 | 0.570 |
Why?
|
Karyotyping | 3 | 2016 | 1171 | 0.570 |
Why?
|
Genes, erbB-1 | 3 | 2020 | 160 | 0.560 |
Why?
|
In Situ Hybridization | 5 | 2021 | 1900 | 0.550 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2016 | 12 | 0.550 |
Why?
|
Ovarian Neoplasms | 7 | 2023 | 4878 | 0.550 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2017 | 1375 | 0.540 |
Why?
|
Thoracic Surgery | 1 | 2023 | 725 | 0.540 |
Why?
|
Pathology, Clinical | 6 | 2024 | 375 | 0.530 |
Why?
|
Adult | 104 | 2024 | 219994 | 0.530 |
Why?
|
Exons | 8 | 2024 | 2388 | 0.520 |
Why?
|
Ubiquitin Thiolesterase | 4 | 2023 | 454 | 0.510 |
Why?
|
Lung | 24 | 2023 | 9994 | 0.510 |
Why?
|
Reagent Strips | 1 | 2015 | 39 | 0.500 |
Why?
|
Sequence Analysis, DNA | 10 | 2019 | 4713 | 0.480 |
Why?
|
ras Proteins | 8 | 2020 | 1052 | 0.480 |
Why?
|
Gene Silencing | 2 | 2020 | 1513 | 0.470 |
Why?
|
Proto-Oncogene Proteins B-raf | 8 | 2020 | 2053 | 0.460 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2018 | 929 | 0.460 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2019 | 380 | 0.460 |
Why?
|
Early Detection of Cancer | 5 | 2021 | 3202 | 0.450 |
Why?
|
Uterine Neoplasms | 6 | 2022 | 1439 | 0.450 |
Why?
|
Trans-Activators | 2 | 2023 | 2860 | 0.450 |
Why?
|
Immunotherapy | 14 | 2024 | 4642 | 0.450 |
Why?
|
Physician's Role | 1 | 2020 | 918 | 0.440 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3610 | 0.430 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 36 | 0.420 |
Why?
|
Brain Neoplasms | 7 | 2024 | 8986 | 0.420 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 547 | 0.420 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2020 | 502 | 0.400 |
Why?
|
Prognosis | 29 | 2024 | 29658 | 0.400 |
Why?
|
Glomus Tumor | 2 | 2022 | 62 | 0.400 |
Why?
|
Granulosa Cell Tumor | 2 | 2023 | 72 | 0.390 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 3 | 2020 | 194 | 0.380 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 3224 | 0.370 |
Why?
|
Molecular Targeted Therapy | 10 | 2020 | 2803 | 0.360 |
Why?
|
Polymerase Chain Reaction | 5 | 2024 | 6068 | 0.360 |
Why?
|
Microsatellite Instability | 6 | 2023 | 715 | 0.360 |
Why?
|
Adenosarcoma | 3 | 2021 | 36 | 0.360 |
Why?
|
DNA-Binding Proteins | 5 | 2023 | 9585 | 0.350 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2022 | 2919 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 15 | 2022 | 17790 | 0.350 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21025 | 0.350 |
Why?
|
Antineoplastic Agents | 14 | 2023 | 13630 | 0.350 |
Why?
|
Neurofibromin 2 | 2 | 2022 | 270 | 0.340 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 733 | 0.340 |
Why?
|
Retrospective Studies | 39 | 2024 | 80372 | 0.330 |
Why?
|
Mediastinal Neoplasms | 1 | 2012 | 402 | 0.330 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 938 | 0.330 |
Why?
|
Genetic Testing | 7 | 2022 | 3531 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 995 | 0.330 |
Why?
|
Sensitivity and Specificity | 14 | 2024 | 14660 | 0.330 |
Why?
|
Metaplasia | 2 | 2020 | 320 | 0.320 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2895 | 0.320 |
Why?
|
Autopsy | 4 | 2022 | 1007 | 0.320 |
Why?
|
Melanoma | 5 | 2021 | 5697 | 0.320 |
Why?
|
Neoadjuvant Therapy | 6 | 2023 | 2821 | 0.310 |
Why?
|
Leukemia | 1 | 2017 | 1520 | 0.310 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2882 | 0.300 |
Why?
|
Gene Dosage | 3 | 2016 | 1218 | 0.300 |
Why?
|
Neoplasm Staging | 14 | 2022 | 11152 | 0.290 |
Why?
|
Mannose-Binding Lectins | 1 | 2007 | 96 | 0.280 |
Why?
|
Genes, Tumor Suppressor | 2 | 2022 | 1055 | 0.280 |
Why?
|
Young Adult | 32 | 2023 | 58741 | 0.280 |
Why?
|
Membrane Proteins | 9 | 2020 | 7850 | 0.280 |
Why?
|
Diagnosis, Differential | 13 | 2022 | 12965 | 0.280 |
Why?
|
DNA Copy Number Variations | 7 | 2022 | 2013 | 0.280 |
Why?
|
Genes, ras | 3 | 2020 | 655 | 0.270 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2022 | 331 | 0.270 |
Why?
|
Lung Diseases, Interstitial | 3 | 2020 | 911 | 0.270 |
Why?
|
Antigens, CD | 3 | 2018 | 4000 | 0.260 |
Why?
|
Cell Differentiation | 6 | 2020 | 11481 | 0.260 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2532 | 0.260 |
Why?
|
Genital Neoplasms, Female | 2 | 2022 | 533 | 0.260 |
Why?
|
Seminoma | 2 | 2023 | 134 | 0.250 |
Why?
|
Lung Transplantation | 3 | 2023 | 1305 | 0.250 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2007 | 169 | 0.250 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2526 | 0.250 |
Why?
|
Smoking | 8 | 2022 | 9073 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2023 | 1088 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 12 | 2019 | 20509 | 0.250 |
Why?
|
Endodermal Sinus Tumor | 2 | 2022 | 53 | 0.240 |
Why?
|
ADAM Proteins | 2 | 2018 | 240 | 0.240 |
Why?
|
Adenoma | 3 | 2021 | 2148 | 0.240 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2018 | 270 | 0.240 |
Why?
|
Pulmonary Artery | 2 | 2024 | 1921 | 0.230 |
Why?
|
Acrylamides | 4 | 2020 | 260 | 0.230 |
Why?
|
Pyridines | 6 | 2021 | 2879 | 0.230 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2017 | 262 | 0.230 |
Why?
|
DNA Helicases | 5 | 2023 | 854 | 0.230 |
Why?
|
beta Catenin | 2 | 2022 | 1043 | 0.230 |
Why?
|
Gene Expression | 3 | 2020 | 7588 | 0.230 |
Why?
|
Lung Diseases | 3 | 2017 | 1915 | 0.230 |
Why?
|
Sertoli-Leydig Cell Tumor | 1 | 2023 | 19 | 0.230 |
Why?
|
Immunophenotyping | 4 | 2024 | 1871 | 0.230 |
Why?
|
Lectins, C-Type | 1 | 2007 | 587 | 0.230 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2023 | 2864 | 0.230 |
Why?
|
Biological Products | 2 | 2023 | 916 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 4 | 2022 | 2802 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2015 | 211 | 0.220 |
Why?
|
Genotype | 9 | 2021 | 12960 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 700 | 0.220 |
Why?
|
Mediastinum | 2 | 2021 | 266 | 0.220 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7475 | 0.210 |
Why?
|
Positron-Emission Tomography | 4 | 2015 | 6465 | 0.210 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9411 | 0.210 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1557 | 0.210 |
Why?
|
Carcinoid Tumor | 2 | 2014 | 228 | 0.210 |
Why?
|
Adaptive Immunity | 2 | 2019 | 726 | 0.210 |
Why?
|
Indazoles | 1 | 2024 | 302 | 0.210 |
Why?
|
Rete Testis | 1 | 2022 | 10 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 225 | 0.210 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4319 | 0.210 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2017 | 517 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.200 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2022 | 34 | 0.200 |
Why?
|
Adenomatoid Tumor | 1 | 2022 | 12 | 0.200 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 102 | 0.200 |
Why?
|
Rhabdomyoma | 1 | 2022 | 54 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Oncogene Fusion | 2 | 2021 | 81 | 0.200 |
Why?
|
Observer Variation | 5 | 2020 | 2601 | 0.200 |
Why?
|
Genital Neoplasms, Male | 1 | 2022 | 68 | 0.200 |
Why?
|
Gene Deletion | 2 | 2021 | 2668 | 0.200 |
Why?
|
Phenotype | 10 | 2022 | 16546 | 0.200 |
Why?
|
Medical Oncology | 4 | 2023 | 2313 | 0.200 |
Why?
|
Kidney Neoplasms | 4 | 2022 | 4312 | 0.200 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.200 |
Why?
|
Leiomyomatosis | 1 | 2022 | 69 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2023 | 9276 | 0.190 |
Why?
|
Granular Cell Tumor | 1 | 2021 | 48 | 0.190 |
Why?
|
Mice | 25 | 2023 | 81208 | 0.190 |
Why?
|
Leydig Cell Tumor | 1 | 2021 | 28 | 0.190 |
Why?
|
Acetonitriles | 1 | 2021 | 54 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11712 | 0.190 |
Why?
|
Chromosome Aberrations | 5 | 2023 | 1764 | 0.180 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 161 | 0.180 |
Why?
|
Uterine Diseases | 1 | 2021 | 117 | 0.180 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2020 | 24 | 0.180 |
Why?
|
Papilloma | 1 | 2021 | 141 | 0.180 |
Why?
|
ras-GRF1 | 1 | 2020 | 26 | 0.180 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 3 | 2022 | 3218 | 0.180 |
Why?
|
Pelvic Neoplasms | 1 | 2022 | 248 | 0.180 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 119 | 0.180 |
Why?
|
Reproducibility of Results | 13 | 2024 | 20080 | 0.180 |
Why?
|
GTP Phosphohydrolases | 4 | 2020 | 518 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Receptor, trkA | 2 | 2022 | 159 | 0.170 |
Why?
|
Polyps | 1 | 2021 | 197 | 0.170 |
Why?
|
Survival Rate | 9 | 2023 | 12808 | 0.170 |
Why?
|
Antibodies, Monoclonal | 6 | 2018 | 9185 | 0.170 |
Why?
|
NF-E2-Related Factor 2 | 4 | 2024 | 376 | 0.170 |
Why?
|
Pyrazoles | 4 | 2022 | 1999 | 0.170 |
Why?
|
Immunoenzyme Techniques | 3 | 2013 | 1705 | 0.170 |
Why?
|
Pulmonary Atelectasis | 1 | 2020 | 143 | 0.170 |
Why?
|
Syndecan-2 | 1 | 2019 | 23 | 0.170 |
Why?
|
Hong Kong | 1 | 2019 | 162 | 0.170 |
Why?
|
Predictive Value of Tests | 8 | 2021 | 15289 | 0.170 |
Why?
|
Germ-Line Mutation | 5 | 2023 | 1841 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2020 | 8515 | 0.170 |
Why?
|
Aniline Compounds | 3 | 2020 | 1069 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2022 | 524 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 45 | 0.160 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2019 | 84 | 0.160 |
Why?
|
Animals | 31 | 2023 | 167963 | 0.160 |
Why?
|
Mullerian Ducts | 2 | 2018 | 201 | 0.160 |
Why?
|
Granuloma | 2 | 2018 | 327 | 0.160 |
Why?
|
Pyrimidines | 4 | 2022 | 3016 | 0.160 |
Why?
|
Point Mutation | 2 | 2022 | 1594 | 0.160 |
Why?
|
Benzamides | 1 | 2024 | 1369 | 0.160 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 237 | 0.160 |
Why?
|
Adnexal Diseases | 1 | 2019 | 106 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 41 | 0.160 |
Why?
|
Biopsy | 7 | 2021 | 6771 | 0.160 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 11345 | 0.150 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.150 |
Why?
|
Proteomics | 3 | 2023 | 3817 | 0.150 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2543 | 0.150 |
Why?
|
Urethra | 1 | 2020 | 406 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 994 | 0.150 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2018 | 45 | 0.150 |
Why?
|
Thyroid Neoplasms | 3 | 2016 | 2332 | 0.150 |
Why?
|
Follow-Up Studies | 12 | 2021 | 39261 | 0.150 |
Why?
|
Anilides | 2 | 2018 | 409 | 0.150 |
Why?
|
Testis | 1 | 2021 | 794 | 0.150 |
Why?
|
Tumor Microenvironment | 6 | 2023 | 3844 | 0.150 |
Why?
|
Immediate-Early Proteins | 1 | 2020 | 449 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2023 | 951 | 0.150 |
Why?
|
Societies, Medical | 7 | 2020 | 3905 | 0.150 |
Why?
|
Data Display | 1 | 2018 | 174 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2021 | 657 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 586 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2021 | 680 | 0.140 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 530 | 0.140 |
Why?
|
Adolescent | 15 | 2023 | 87810 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2471 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4573 | 0.140 |
Why?
|
Formaldehyde | 2 | 2017 | 358 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 724 | 0.140 |
Why?
|
Treatment Outcome | 19 | 2023 | 65017 | 0.140 |
Why?
|
Pathology | 1 | 2020 | 270 | 0.140 |
Why?
|
Interferons | 1 | 2020 | 705 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2003 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2017 | 895 | 0.140 |
Why?
|
MAP Kinase Signaling System | 3 | 2020 | 1484 | 0.140 |
Why?
|
Disease Models, Animal | 10 | 2023 | 18137 | 0.140 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2017 | 62 | 0.140 |
Why?
|
Respiratory System | 1 | 2020 | 557 | 0.140 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5351 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 278 | 0.140 |
Why?
|
Oximes | 1 | 2018 | 306 | 0.140 |
Why?
|
Thoracic Diseases | 1 | 2017 | 99 | 0.140 |
Why?
|
Cell Line, Tumor | 12 | 2021 | 16939 | 0.140 |
Why?
|
Larynx | 1 | 2021 | 492 | 0.130 |
Why?
|
World Health Organization | 3 | 2021 | 1312 | 0.130 |
Why?
|
Neurofibromatosis 2 | 1 | 2020 | 385 | 0.130 |
Why?
|
Skin Neoplasms | 4 | 2022 | 5799 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2021 | 560 | 0.130 |
Why?
|
Airway Obstruction | 1 | 2021 | 662 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 786 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 949 | 0.130 |
Why?
|
Pneumonia | 3 | 2017 | 2131 | 0.130 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 800 | 0.130 |
Why?
|
Quinoxalines | 1 | 2018 | 297 | 0.130 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 304 | 0.130 |
Why?
|
Mesonephroma | 1 | 2015 | 21 | 0.130 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.130 |
Why?
|
Nevus, Pigmented | 1 | 2018 | 221 | 0.130 |
Why?
|
Prostate | 2 | 2021 | 1793 | 0.130 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2015 | 30 | 0.130 |
Why?
|
Receptors, Notch | 1 | 2020 | 743 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2020 | 607 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1110 | 0.130 |
Why?
|
Bronchiolitis Obliterans | 1 | 2017 | 213 | 0.130 |
Why?
|
Tissue Embedding | 1 | 2015 | 42 | 0.130 |
Why?
|
Signal Transduction | 10 | 2021 | 23376 | 0.130 |
Why?
|
Pyrimidinones | 1 | 2018 | 384 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 796 | 0.130 |
Why?
|
B-Cell Activating Factor | 1 | 2015 | 115 | 0.130 |
Why?
|
DNA Polymerase II | 1 | 2015 | 104 | 0.120 |
Why?
|
Cytodiagnosis | 1 | 2019 | 442 | 0.120 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 77 | 0.120 |
Why?
|
Paper | 1 | 2015 | 85 | 0.120 |
Why?
|
Specimen Handling | 2 | 2021 | 707 | 0.120 |
Why?
|
Diamines | 1 | 2015 | 59 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 611 | 0.120 |
Why?
|
Mucins | 2 | 2020 | 568 | 0.120 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.120 |
Why?
|
Myofibroma | 1 | 2015 | 45 | 0.120 |
Why?
|
Cell Lineage | 3 | 2018 | 2533 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 495 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3602 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 717 | 0.120 |
Why?
|
Melanocytes | 1 | 2018 | 512 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 6 | 2017 | 6544 | 0.120 |
Why?
|
Endothelium | 1 | 2017 | 764 | 0.120 |
Why?
|
S100 Proteins | 2 | 2022 | 218 | 0.120 |
Why?
|
Gene Library | 1 | 2017 | 1060 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1677 | 0.120 |
Why?
|
Prednisone | 1 | 2019 | 1565 | 0.120 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.120 |
Why?
|
Diagnostic Imaging | 3 | 2018 | 3527 | 0.120 |
Why?
|
Mediastinal Cyst | 1 | 2014 | 29 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4742 | 0.120 |
Why?
|
Organic Chemicals | 1 | 2015 | 211 | 0.120 |
Why?
|
Facial Dermatoses | 1 | 2014 | 85 | 0.120 |
Why?
|
Lymphatic Metastasis | 2 | 2023 | 2943 | 0.120 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 688 | 0.120 |
Why?
|
Benzothiazoles | 1 | 2015 | 246 | 0.120 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2014 | 102 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.110 |
Why?
|
Paraffin Embedding | 2 | 2017 | 302 | 0.110 |
Why?
|
DNA Repair | 2 | 2020 | 2039 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 559 | 0.110 |
Why?
|
Urinary Bladder | 1 | 2020 | 1166 | 0.110 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.110 |
Why?
|
Lymphoid Tissue | 1 | 2015 | 445 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 266 | 0.110 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.110 |
Why?
|
Epithelial Cells | 3 | 2020 | 3663 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 717 | 0.110 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 321 | 0.110 |
Why?
|
Teratoma | 1 | 2016 | 403 | 0.110 |
Why?
|
Succinate Dehydrogenase | 1 | 2014 | 145 | 0.110 |
Why?
|
Receptor, trkB | 1 | 2014 | 125 | 0.110 |
Why?
|
Mucin-1 | 1 | 2018 | 539 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.110 |
Why?
|
Acute Disease | 2 | 2017 | 7269 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 635 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.110 |
Why?
|
Cohort Studies | 13 | 2023 | 41335 | 0.110 |
Why?
|
Piperazines | 2 | 2021 | 2525 | 0.110 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2013 | 60 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 424 | 0.110 |
Why?
|
Tissue Array Analysis | 3 | 2019 | 551 | 0.100 |
Why?
|
Quinazolines | 2 | 2017 | 1363 | 0.100 |
Why?
|
Pyridones | 1 | 2018 | 792 | 0.100 |
Why?
|
RNA, Viral | 1 | 2021 | 2838 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 604 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4550 | 0.100 |
Why?
|
Nucleic Acids | 1 | 2014 | 188 | 0.100 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.100 |
Why?
|
Bronchial Hyperreactivity | 1 | 2013 | 302 | 0.100 |
Why?
|
Imidazoles | 1 | 2018 | 1180 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2058 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2023 | 2566 | 0.100 |
Why?
|
Patient Selection | 3 | 2019 | 4283 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2852 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1998 | 0.100 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4902 | 0.100 |
Why?
|
Child | 10 | 2023 | 79806 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2013 | 492 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 650 | 0.090 |
Why?
|
Boston | 3 | 2019 | 9280 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 478 | 0.090 |
Why?
|
Tumor Escape | 1 | 2013 | 370 | 0.090 |
Why?
|
Thyroid Gland | 2 | 2016 | 1168 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2019 | 10446 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1869 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2622 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2276 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1628 | 0.090 |
Why?
|
Chromosomes | 2 | 2023 | 575 | 0.090 |
Why?
|
Quinolines | 1 | 2015 | 759 | 0.080 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2009 | 88 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9530 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1765 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1173 | 0.080 |
Why?
|
Meningioma | 1 | 2018 | 1221 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 2448 | 0.080 |
Why?
|
Toll-Like Receptor 9 | 1 | 2010 | 234 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1249 | 0.080 |
Why?
|
Thymus Gland | 1 | 2014 | 1247 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2557 | 0.080 |
Why?
|
Aneuploidy | 2 | 2023 | 551 | 0.080 |
Why?
|
Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1356 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1423 | 0.080 |
Why?
|
Oncogenes | 3 | 2021 | 1220 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15687 | 0.080 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2008 | 19 | 0.080 |
Why?
|
Proportional Hazards Models | 4 | 2023 | 12531 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3618 | 0.080 |
Why?
|
Ligands | 3 | 2021 | 3276 | 0.080 |
Why?
|
Risk Factors | 10 | 2023 | 74359 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2010 | 345 | 0.080 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6131 | 0.080 |
Why?
|
Chromogenic Compounds | 1 | 2007 | 31 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1500 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2016 | 10181 | 0.070 |
Why?
|
Thrombomodulin | 1 | 2008 | 105 | 0.070 |
Why?
|
Chimera | 1 | 2009 | 453 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 54303 | 0.070 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.070 |
Why?
|
Discriminant Analysis | 1 | 2007 | 223 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2010 | 649 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1898 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1913 | 0.070 |
Why?
|
Mitosis | 2 | 2023 | 1191 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2488 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.070 |
Why?
|
Pathology, Surgical | 2 | 2019 | 151 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3584 | 0.070 |
Why?
|
Cell Nucleus | 3 | 2019 | 2907 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1511 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5785 | 0.070 |
Why?
|
Placenta Diseases | 1 | 2008 | 196 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15620 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 1007 | 0.060 |
Why?
|
DNA Methylation | 2 | 2017 | 4373 | 0.060 |
Why?
|
United States | 9 | 2023 | 72461 | 0.060 |
Why?
|
Consensus | 3 | 2021 | 3113 | 0.060 |
Why?
|
Janus Kinase 2 | 1 | 2008 | 542 | 0.060 |
Why?
|
Antigens, CD1 | 1 | 2007 | 439 | 0.060 |
Why?
|
NIH 3T3 Cells | 2 | 2017 | 670 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2020 | 5201 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22023 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 785 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3607 | 0.060 |
Why?
|
Immunity | 2 | 2020 | 998 | 0.060 |
Why?
|
Ifosfamide | 1 | 2023 | 232 | 0.050 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3707 | 0.050 |
Why?
|
Inflammation | 4 | 2023 | 10756 | 0.050 |
Why?
|
False Positive Reactions | 2 | 2016 | 956 | 0.050 |
Why?
|
Pilot Projects | 3 | 2021 | 8555 | 0.050 |
Why?
|
Synaptophysin | 1 | 2022 | 139 | 0.050 |
Why?
|
SOXD Transcription Factors | 1 | 2022 | 44 | 0.050 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2023 | 276 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2049 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5206 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2023 | 430 | 0.050 |
Why?
|
Cell Cycle | 2 | 2022 | 2934 | 0.050 |
Why?
|
Disease Progression | 5 | 2019 | 13502 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 52 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2627 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 195 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6551 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Survival Analysis | 3 | 2019 | 10182 | 0.050 |
Why?
|
Ribonuclease III | 1 | 2023 | 279 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6828 | 0.050 |
Why?
|
Up-Regulation | 2 | 2021 | 4122 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 201 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10547 | 0.050 |
Why?
|
Benzoxazoles | 1 | 2022 | 89 | 0.050 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2022 | 232 | 0.050 |
Why?
|
Apoptosis | 4 | 2020 | 9501 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 156 | 0.050 |
Why?
|
Trophoblastic Neoplasms | 1 | 2020 | 88 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 1 | 2023 | 383 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2021 | 14372 | 0.040 |
Why?
|
DNA Damage | 2 | 2020 | 2442 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
Cell Survival | 2 | 2020 | 5797 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 1 | 2021 | 162 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Incidence | 2 | 2023 | 21392 | 0.040 |
Why?
|
Syntenins | 1 | 2019 | 8 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2020 | 376 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2017 | 1738 | 0.040 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2021 | 296 | 0.040 |
Why?
|
Thrombosis | 2 | 2017 | 3052 | 0.040 |
Why?
|
Gene Frequency | 2 | 2017 | 3615 | 0.040 |
Why?
|
Neurosecretory Systems | 1 | 2020 | 221 | 0.040 |
Why?
|
Asia | 1 | 2021 | 620 | 0.040 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 326 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5649 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18416 | 0.040 |
Why?
|
Receptors, Prostaglandin | 1 | 2018 | 53 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2013 | 1737 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2007 | 878 | 0.040 |
Why?
|
Protein Phosphatase 2 | 1 | 2020 | 236 | 0.040 |
Why?
|
Radiation Pneumonitis | 1 | 2019 | 102 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7343 | 0.040 |
Why?
|
Hematoxylin | 1 | 2018 | 60 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2018 | 69 | 0.040 |
Why?
|
Fibroblasts | 2 | 2022 | 4090 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2020 | 877 | 0.040 |
Why?
|
Algorithms | 2 | 2023 | 13981 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 251 | 0.040 |
Why?
|
Recurrence | 1 | 2010 | 8482 | 0.040 |
Why?
|
Sheep | 1 | 2020 | 1441 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 238 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 642 | 0.040 |
Why?
|
Tablets | 1 | 2018 | 149 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2938 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 635 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 141 | 0.040 |
Why?
|
Tennessee | 1 | 2017 | 119 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.040 |
Why?
|
Base Sequence | 2 | 2020 | 12446 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2520 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 333 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1044 | 0.040 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2017 | 64 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2018 | 320 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2021 | 697 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2001 | 1130 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3602 | 0.030 |
Why?
|
Introns | 1 | 2019 | 978 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22053 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2262 | 0.030 |
Why?
|
Stromal Cells | 1 | 2022 | 1326 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1754 | 0.030 |
Why?
|
Keratinocytes | 1 | 2020 | 792 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2018 | 459 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 372 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 704 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 479 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12922 | 0.030 |
Why?
|
Mice, Nude | 2 | 2015 | 3607 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2019 | 632 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 805 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8313 | 0.030 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12626 | 0.030 |
Why?
|
Trachea | 1 | 2021 | 1082 | 0.030 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
Risk Assessment | 2 | 2022 | 24123 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2021 | 911 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1077 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1832 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 548 | 0.030 |
Why?
|
Pulmonary Medicine | 1 | 2017 | 221 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1612 | 0.030 |
Why?
|
Mast Cells | 1 | 2022 | 1390 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2014 | 6216 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2049 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15697 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2536 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3804 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1082 | 0.030 |
Why?
|
Asthma | 1 | 2013 | 6172 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2020 | 933 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1547 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3441 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1266 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 349 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 184 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 143 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 798 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1089 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 2015 | 404 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 600 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2020 | 977 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2014 | 193 | 0.030 |
Why?
|
Genome, Human | 2 | 2017 | 4417 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 3969 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2015 | 659 | 0.030 |
Why?
|
Safety | 1 | 2018 | 1148 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 748 | 0.030 |
Why?
|
Models, Biological | 2 | 2020 | 9467 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2013 | 203 | 0.030 |
Why?
|
Teaching | 1 | 2020 | 1169 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 618 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5745 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 454 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2722 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1411 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 1096 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2017 | 520 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2440 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3446 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2981 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2001 | 1155 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3322 | 0.020 |
Why?
|
Codon | 1 | 2013 | 602 | 0.020 |
Why?
|
Intestines | 1 | 2020 | 1907 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1060 | 0.020 |
Why?
|
Infant | 3 | 2023 | 36060 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2014 | 1753 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2529 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3084 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 734 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8158 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2018 | 1535 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1591 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 983 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2042 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1837 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2618 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1617 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9716 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2014 | 1553 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1132 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2414 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4810 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 40165 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4578 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1881 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42063 | 0.020 |
Why?
|
Eosinophils | 1 | 2013 | 944 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2873 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3800 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3529 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8552 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 830 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15789 | 0.020 |
Why?
|
Medical Records | 1 | 2013 | 1407 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1895 | 0.020 |
Why?
|
Molecular Probes | 1 | 2009 | 313 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2583 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1959 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5434 | 0.020 |
Why?
|
Biological Assay | 1 | 2009 | 630 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3106 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1221 | 0.020 |
Why?
|
Antibodies | 1 | 2014 | 2421 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2008 | 463 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1724 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2010 | 730 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1456 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6898 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23711 | 0.020 |
Why?
|
Thrombophilia | 1 | 2008 | 306 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3600 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3340 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6786 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2009 | 1493 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3025 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2017 | 3539 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.010 |
Why?
|
Hospitals, General | 1 | 2008 | 795 | 0.010 |
Why?
|
DNA, Viral | 1 | 2010 | 2194 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4775 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4773 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26181 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5496 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4783 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1674 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2008 | 1157 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25942 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5039 | 0.010 |
Why?
|
Concanavalin A | 1 | 2001 | 190 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 2001 | 246 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2001 | 306 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2693 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2379 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14495 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2001 | 915 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2001 | 381 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36290 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5870 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 1433 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4291 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15840 | 0.010 |
Why?
|
Mothers | 1 | 2008 | 2186 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4541 | 0.010 |
Why?
|
Species Specificity | 1 | 2001 | 2418 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2298 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7593 | 0.000 |
Why?
|
Pregnancy | 1 | 2008 | 29749 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2001 | 18957 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11903 | 0.000 |
Why?
|